A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic...

Area of Science:

• Psychopharmacology
• Neuroscience
• Psychedelic Research

Background:

• N,N-dimethyltryptamine (DMT) induces profound altered states of consciousness, characterized by vivid alternate realities and complex phenomena.
• The short duration of DMT effects (under 20 minutes) poses challenges for detailed psychological and neuroimaging research.
• Understanding the phenomenology of DMT-induced states is crucial for psychology and requires advanced research methodologies.

Purpose of the Study:

• To propose and validate a novel method for prolonged N,N-dimethyltryptamine (DMT) administration suitable for rigorous scientific inquiry.
• To overcome the limitations of short-acting psychedelics in research settings.
• To facilitate detailed psychological observation and functional neuroimaging during DMT-induced states.

Main Methods:

• Utilizing pharmacokinetic modeling and existing DMT blood sampling data.
• Simulating the administration of DMT via target-controlled intravenous infusion (TCII).
• Leveraging TCII technology, commonly used for maintaining stable anesthetic drug concentrations.

Main Results:

• Pharmacokinetic modeling indicates that DMT's properties (rapid onset, lack of acute tolerance) are amenable to TCII.
• Simulations demonstrate TCII can achieve stable and prolonged DMT plasma concentrations, inducing extended subjective experiences.
• This approach allows for sustained observation of psychological content and functional neuroimaging.

Conclusions:

• Target-controlled intravenous infusion offers a viable method for prolonged DMT administration in research.
• This technique overcomes the temporal limitations of DMT, enabling deeper investigation into its psychological effects.
• Prolonged DMT infusion may unlock new avenues for psychedelic research and psychotherapeutic applications.